F.Hoffmann-La Roche Ltd, Merck KGaA and Abbott are dominating the Global LDL Test Market in the year 2019

Global LDL test market is expected to reach USD 1,688.73 million by 2026 growing at a substantial CAGR in the forecast period of 2019 to 2026. The years considered for study are as mentioned below.

Access Full Report at https://databridgemarketresearch.com/reports/global-ldl-test-market/

Global LDL test market is a highly concentrated market which includes key players and local players. The market has witnessed various strategic developments owing to favourable market scenario. The market has a prominent growth in upcoming years due to rising awareness among patient, increasing prevalence of cardiovascular diseases and obesity, increasing number of geriatric people. High growth possibility in LDL test in developing countries is also posing as an opportunity for the market.

The market has witness developments in terms of merger and acquisitions or product launches to enhance the product portfolio to meet the rising demand of innovative technology. For instance, In October 2017, Abbott (U.S) acquired Alere Laboratory (U.S). Abbott paid USD 5.8 Billion to Alere and as per the agreement Alere has become subsidiary of Abbott. By this acquisition company enhance their business and capture more market share.

F. Hoffmann-La Roche Ltd dominated the global LDL test market and accounts for the highest market share in 2018 which is followed by Merck KGaA and Abbott. Some of the major players in the market are Express Biotech International, Randox Laboratories Ltd, Reckon diagnostics, Diasys Diagnostic Systems GmbH, Eurolyser Diagnostica GmbH, Sigma-Aldrich, Diazyme Laboratories, Inc, Laboratory Corporation of America, Cell Biolabs, Inc, Atlas Medical U.K, Eurofins Scientific, Thermo Fisher Scientific Inc, Home Access Health and others.

F. Hoffmann-La Roche Ltd

F. Hoffmann-La Roche Ltd headquartered in Basel, Switzerland was founded in 1896. The company focuses on the development, sales and manufacturing of pharmaceuticals and diagnostics products. The company has two operating divisions’ pharmaceuticals, diagnostics. The diagnostics is market focused segment. Company has wide range of product categories such as pharmaceuticals, solutions for diagnostics, products for researchers and solutions for diagnostics is market focused category.

The company has its global presence in Europe, North America, Asia, Africa, Australia and Oceania. The company has various subsidiaries such as Genentech, Inc. (U.S), Roche Diagnostics Limited (U.K), Chugai Pharmaceutical Co (Japan), Flatiron Health, Inc. (U.S), Ventana Medical Systems (U.S), Kapa Biosystems, Inc (U.S).


MERCK KGA headquartered Darmstadt, Germany, was founded in 1995. The company focuses on the development and manufacturing of medicines and intelligent devices that provide ongoing care for patients beyond their treatment. The company operates through three business segments which include Lifescience, Healthcare and Performance Material. The Lifescience segment is the market focused segment.

The company has its global presence in North America, Asia-Pacific, Middle East & Africa and it operates through its subsidiaries such as Sigma-Aldrich (U.S), Merck Millipore Limited (Ireland), Allergo pharma GmbH & Co. KG (Germany), MERCK, S.L.U (Spain), Merck (Pvt) Ltd (Pakistan), Seven Seas Ltd (U.K).


Abbott headquartered in Illinois, U.S. was founded in 1888. The company is focused on manufactures products for diagnostics, medical devices, nutrition and branded generic pharmaceuticals. The company operate their business in five business segments as established pharmaceuticals, nutritionals, diagnostics, cardiovascular and neuromodulation, other.

The company has its global presence in Americas, Asia Pacific, Europe, Middle East and South Africa. It operates through its subsidiaries such as Alere Inc. (U.S.), Abbott Medical Optics Inc. (U.S.), EAS (U.S.), Abbott India Ltd (India), Thoratec Corporation (U.S.), Abbott Informatics (U.S.), CardioMEMS (U.S.), CFR Pharmaceuticals (Chile), Abbott GmbH & Co. KG (Germany) and others.